Biomedicine is a top priority for Taiwan, with the government aiming to position the country as the leading hub for biomedical research and development in the Asia-Pacific region. By 2025, Taiwan aims to create 20 new medicines, introduce 80 high-value medical devices to the market, and elevate the biomedicine industry into a trillion-NT-dollar (approximately $32 […]
Plain Language Summary The current study explores the association between metabolic associated fatty liver disease (MAFLD) and chronic hepatitis B-related hepatocellular carcinoma (HBV-HCC) in terms of the prognosis. It shows that HBV-related HCC patients with MAFLD have a better outcome than those without MAFLD. Risk factors for HCC, such as positive HBeAg (Hepatitis B e-antigen), […]
Abstract Hepatocellular carcinoma is a leading cause of cancer-related deaths due to its complexity in diagnosis, chemo-resistance, and aggressive nature. Identifying pathogenic single nucleotide polymorphism (SNP) in protein kinase C iota (PKCι) can be a potential biomarker in the prognosis and treatment of HCC. This study investigated the association between a SNP in PRKCI and […]
Abstract The impact of inflammatory markers such as systemic immune-inflammation (SII) index and systemic inflammation response index (SIRI) on myelofibrosis (MF) prognosis was evaluated for the first time in this study. Data from 60 patients diagnosed with MF between March 2011 and September 2022 were retrospectively analyzed. In addition to disease-related markers, the impact of […]
Abstract Netrin-1 is upregulated in cancers as a protumoural mechanism1. Here we describe netrin-1 upregulation in a majority of human endometrial carcinomas (ECs) and demonstrate that netrin-1 blockade, using an anti-netrin-1 antibody (NP137), is effective in reduction of tumour progression in an EC mouse model. We next examined the efficacy of NP137, as a first-in-class […]
Newswise — HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a novel biomarker […]
New York, USA, Aug. 02, 2023 (GLOBE NEWSWIRE) — Alzheimer’s Disease Market Predicted to Surge at a CAGR of 20% During the Study Period (2019–2032), Assesses DelveInsight The Alzheimer’s disease market size is projected to grow significantly during the forecast period (2023–2032) owing to the launch of upcoming therapies and the increasing prevalence of the […]
Female operators working in the semiconductor industry in South Korea experienced excess cancer mortality due to malignant neoplasms in the lymphoid, hematopoietic, and related tissues, especially leukemia. Female operators showed a 2.59-fold increased risk of mortality due to malignant neoplasms in the lymphoid, hematopoietic, and related tissues compared with the general population and 2.92-fold increased […]
NEWTON, Mass., Aug. 1, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 26,350 restricted stock units (RSUs) to 4 newly-hired employees. These RSU awards were granted as of July 31, 2023 (the “Grant Date”) pursuant to the Company’s […]
Tue, 01 Aug 2023 21:13:30 GMT (1690924410005) 81d3bb27381112e34f0f4c6b5f0c2b73a019c858 5b635e9d4842dbb4a391dce5e8f747e52a00b730 News Weather Sports Community Game Center Watch Now 81 Wed 86 Thu 89 by Brian Kerhin, FOX 11 News Tue, August 1st 2023, 9:10 PM UTC File photo (WLUK) 0 Loading …